Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies.

Authors:
Chapman TJ; Patel SM; Flores SA; Xu S; Lupinacci R and 10 more

Journal:
Pediatr Infect Dis J

Publication Year: 2023

DOI:
10.1097/INF.0000000000004069

PMCID:
PMC10569678

PMID:
37566897

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pediatr Infect Dis J

Abbreviation: Pediatr Infect Dis J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Clinical and Economic Burden of Antibiotic Use Among Pediatric Patients With Varicella Infection in…
Kujawski SA; Casey CS; Haas H and 4 more (2024) - Transparency Score: 3/6
COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Chi…
Blanchard-Rohner G; Sanchez C; Andre MC and 11 more (2024) - Transparency Score: 3/6
Epidemiology and Clinical Characteristics of Human Metapneumovirus Infections in Hospitalized Child…
Steinberg R; Marty V; Korten I and 3 more (2024) - Transparency Score: 3/6
Risk of SARS-CoV-2 Reinfection in Children Within the 12 Months Following Mild COVID-19: Insights F…
Di Chiara C; Boracchini R; Cantarutti A and 5 more (2024) - Transparency Score: 3/6
Trends in Otitis Media Ambulatory Visits in American Indian and Alaska Native Children During the P…
Bressler SS; Bruden D; Hammitt LL and 3 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"K.B. and L.M. were employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, at the time of the study and may own stock and/or stock options in Merck & Co., Inc., Rahway, NJ. J.K. is an employee of MSD, London, United Kingdom. All other authors are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, and may own stock and/or stock options in Merck & Co., Inc., Rahway, NJ."

Evidence found in paper:

"Funding for this research was provided by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025